# EDGAR Filing Document

**Accession Number:** 0001756770
**File Stem:** 0001104659-23-003038
**Filing Date:** 2023-1
**Character Count:** 96980
**Document Hash:** b214ffce9fa37c0ca9f8c1c2c87bb5a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-003038.hdr.sgml**: 20230111

**ACCESSION NUMBER**: 0001104659-23-003038

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20230111

**FILED AS OF DATE**: 20230111

**DATE AS OF CHANGE**: 20230111

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Curaleaf Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001756770
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-249081
- **FILM NUMBER:** 23523547

**BUSINESS ADDRESS:**
- **STREET 1:** 610 - 700 WEST PENDER STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 1G8
- **BUSINESS PHONE:** 604-218-4766

**MAIL ADDRESS:**
- **STREET 1:** 610 - 700 WEST PENDER STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 1G8

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LEAD VENTURES INC.
- **DATE OF NAME CHANGE:** 20181023

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**<br> **Washington, D.C. 20549**<br>**Form 6-K**<br>**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of January, 2023.

Commission File Number: **333-249081**

**<u>CURALEAF HOLDINGS, INC.</u>**<br> (Exact Name of Registrant as Specified in Charter)<br>**666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8**

**Canada**<br> (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F □ Form 40-F ⌧

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<br>

---

| | | |
|:---|:---|:---|
|  | **CURALEAF HOLDINGS, INC.** | **CURALEAF HOLDINGS, INC.** |
|  | (Registrant) | (Registrant) |
| Date: January 11, 2023 | By: | */s/ Peter Clateman* |
|  | Name: | Peter Clateman |
|  | Title: | Chief Legal Officer  |

---

**<u>EXHIBIT INDEX</u>**

---

| | |
|:---|:---|
| [99.1](tm232711d1_ex99-1.htm) | [Form 9 Notice of Issuance or Proposed Issuance of Listed Securities dated January 5, 2023](tm232711d1_ex99-1.htm) |
| [99.2](tm232711d1_ex99-2.htm) | [Form 7 Monthly Progress Report dated January 8, 2023](tm232711d1_ex99-2.htm) |
| [99.3](tm232711d1_ex99-3.htm) | [Form 6 Certificate of Compliance dated January 9, 2023](tm232711d1_ex99-3.htm) |
| [99.4](tm232711d1_ex99-4.htm) | [Form 9 Notice of Issuance or Proposed Issuance of Listed Securities dated January 10, 2023](tm232711d1_ex99-4.htm) |

---

## Exhibit 99.1

**Exhibit 99.1**

**FORM 9**

**<u>NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES</u>**

**<u>(or securities convertible or exchangeable into listed securities</u><sup>1</sup><u>)</u>**

Name of Listed Issuer: Symbol(s): <br> Curaleaf Holdings, Inc. (the "Issuer"). CURA

Date: <u>January 5, 2023</u> Is this an updating or amending Notice: ⌧Yes ◻No

If yes provide date(s) of prior Notices: <u>January 28, 2019.</u>

Issued and Outstanding Securities of Issuer Prior to Issuance: <u>623,377,025 Subordinate Voting Shares</u>.

**Pricing**

Date of news release announcing proposed issuance: <u>January 10, 2019</u> or

Date of confidential request for price protection: <u>N/A</u>

Closing Market Price on Day Preceding the news release: <u>CAD 7.49</u> or

Day preceding request for price protection: <u>N/A</u>

**Closing**

Number of securities to be issued: <u>355,584 Subordinate Voting Shares.</u>

Issued and outstanding securities following issuance: <u>623,732,609 Subordinate Voting Shares.</u>

**Instructions:**

&nbsp;&nbsp;&nbsp;&nbsp;1. For private placements (including debt settlement), complete tables
 1A and 1B in Part 1 of this form.

&nbsp;&nbsp;&nbsp;&nbsp;2. Complete Table 1A – Summary for all purchasers, excluding those
 identified in Item 8.

&nbsp;&nbsp;&nbsp;&nbsp;3. Complete Table 1B – Related Persons only for Related Persons

&nbsp;&nbsp;&nbsp;&nbsp;4. If shares are being issued in connection with an acquisition (either
 as consideration or to raise funds for a cash acquisition) please proceed to Part 2 of this
 form.

&nbsp;&nbsp;&nbsp;&nbsp;5. An issuance of non-convertible debt does not have to be reported unless
 it is a significant transaction as defined in Policy 7, in which case it is to be reported
 on Form 10 – Notice of Proposed Transaction

**6.** Post the completed Form 9 to the CSE website
 in accordance with *Policy 6 – Distributions.* In addition, the completed form
 must be delivered to <u>listings@thecse.com</u> with an appendix that includes the information
 in Table 1B for ALL placees.

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 1 |

---

**Part 1. Private Placement**

**<u>Table 1A – Summary</u>**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;Each jurisdiction in which<br> purchasers reside | &nbsp;&nbsp; <br> Number of<br> Purchasers | &nbsp;&nbsp; <br> Price per<br> Security | &nbsp;&nbsp; <br> Total dollar value<br> (CDN$) raised in<br> the jurisdiction |
| &nbsp;&nbsp; <br> Total number of purchasers: |  |  |  |
| &nbsp;&nbsp; <br> Total dollar value of distribution in all jurisdictions: | &nbsp;&nbsp; <br> Total dollar value of distribution in all jurisdictions: | &nbsp;&nbsp; <br> Total dollar value of distribution in all jurisdictions: |  |

---

**<u>Table 1B – Related Persons</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| <br> **Full Name** | <br> **Number of** | <br> **Purchase** | <br> **Conversion** | <br> **Prospectus** | <br> **TotalSecurities** | <br> **Payment** | <br> **Describe** |
| &nbsp;&nbsp;**&Municipali** **ty** | **Securities** | **price per** | **Price (if** | &nbsp;&nbsp;&nbsp;**Exemption** | **Previously** | **Date(1)** | **relations** **hip** |
| **of** | **Purchased** | **Security** | **Applicable)** |  | **Owned,** |  | **to** |
| &nbsp;&nbsp;&nbsp;**Residence** | **or to be** | &nbsp;&nbsp;&nbsp;&nbsp;**(CDN$)** | **(CDN$)** |  | **Controlled or** |  | **Issuer (2)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**of Placee** | **Purchased** |  |  |  | **Directed** |  |  |

---

<sup>1</sup>An issuance of non-convertible debt does not have to be reported unless it is a significant transaction as defined in Policy 7, in which case it is to be reported on Form 10.

1. Total
 amount of funds to be raised: .

2. Provide full details of the use of the proceeds. The disclosure should be sufficiently
 complete to enable a reader to appreciate the significance of the transaction without reference to any other
 material. _____________________ .

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 2 |

---

3. Provide particulars of any proceeds which are to be paid to Related Persons of the Issuer: <br>   .

4. If securities are issued in forgiveness of indebtedness, provide details of the debt agreement(s) or
 and the agreement to exchange the debt for securities.

5. Description of securities to be issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Class .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Number .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Price
 per security .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Voting rights

6. Provide the following information if warrants, (options) or other convertible securities are to
 be issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Number .

(b) Number of securities eligible to be purchased on exercise of warrants (or options)  <br>   .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Exercise
 price .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Expiry
 date .

7. Provide the following information if debt securities are to be issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Aggregate
 principal amount .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Maturity
 date .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Interest
 rate .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Conversion
 terms .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Default
 provisions .

8. Provide the following information for any agent's fee, commission, bonus
 or finder's fee, or other compensation paid or to be paid in connection with the placement (including
 warrants, options, etc.):

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 3 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Details
 of any dealer, agent, broker or other person receiving compensation in connection with the
 placement (name, and if a corporation, identify persons owning or exercising voting
 control over 20% or more of the voting shares if known to the Issuer):_____ .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Cash .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Securities .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Other .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Expiry
 date of any options, warrants etc. .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Exercise
 price of any options, warrants etc. .

9. State whether the sales agent, broker, dealer or other person receiving compensation in connection with the placement is Related Person or has any other relationship with the Issuer and provide details of the relationship <br>   .

10. Describe any unusual particulars of the transaction (i.e. tax "flow through" shares, etc.). <br>   .

11. State whether the private placement will result in a change of control. <br>   .

12. Where there is a change in the control of the Issuer resulting from the issuance of the private placement shares, indicate the names of the new controlling shareholders. <br>   <br>   .

13. Each purchaser has been advised of the applicable securities legislation
 restricted or seasoning period. All certificates for securities issued which are subject to a hold
 period bear the appropriate legend restricting their transfer until the expiry of the applicable hold
 period required by National Instrument 45-102 Resale of Securities.

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 4 |

---

**Part 2.** **Acquisition**

1. Provide details of the assets to be acquired
 by the Issuer (including the location of the assets, if applicable). The disclosure should
 be sufficiently complete to enable a reader to appreciate the significance of the transaction
 without reference to any other material:

<u>On December 10, 2018, Curaleaf, Inc. ("Curaleaf"), a wholly-owned subsidiary of the Issuer, as lender, entered into a loan agreement (the "HMS Loan Agreement") with, *inter alios*, HMS Trust A, dated February 28, 2017 ("Trust A") and HMS Trust B, dated February 28, 2017 ("Trust B" and together with Trust A, the "Trusts"), as borrowers, pursuant to which Curaleaf had agreed to extend a loan in the amount of USD 29,000,000 to the Trusts. Under the HMS Loan Agreement, the Trusts had agreed to sell to Curaleaf 5% of the membership interests of HMS Processing LLC (the "HMS Processing 5% Interests"), in consideration of which Curaleaf would cause the Issuer to issue to the Trusts a certain amount of subordinate voting shares in the capital of the Issuer (the "Subordinate Voting Shares") having an aggregate value equal to USD 2,000,000 (subject to certain purchase price adjustments provided for in the HMS Loan Agreement) divided by the thirty (30)-day volume weighted average price (VWAP) as of the date of issuance of such Subordinate Voting Shares (the "Share Consideration").</u> 

<u>On September 28, 2022 (the "Effective Date"), the HMS Loan Agreement was amended pursuant to an Amendment to Loan Agreement of even date among, *inter alios*, Curaleaf and the Trusts, whereby the parties agreed to amend the Share Consideration, in order to provide that Curaleaf would cause the Issuer to issue an aggregate of 355,584 Subordinate Voting Shares to the Trusts on January 5, 2023, in consideration for the HMS Processing 5% Interests.</u> 

<u>On the Effective Date, and as a condition of each Trust's receipt of its portion of the Share Consideration, the Issuer also entered into two distinct subscription agreements with Curaleaf and each of the Trusts, whereby the Issuer agreed to issue the Share Consideration, as amended, to the Trusts, in consideration for the transfer of the HMS Processing 5% Interests to Curaleaf as of the Effective Date.</u>

2. Provide details of the acquisition including
 the date, parties to and type of agreement (eg: sale, option, license etc.) and relationship
 to the Issuer. The disclosure should be sufficiently complete to enable a reader to appreciate
 the significance of the acquisition without reference to any other material:

<u>Please refer to Item 1 above.</u>

3. Provide the following information in relation
 to the total consideration for the acquisition (including details of all cash, securities
 or other consideration) and any required work commitments:

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 5 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Total
 aggregate consideration in Canadian dollars: <u>Approximately CAD 1.94 million (based on the closing price of the Subordinate Voting Shares on the CSE on January 3, 2023 of CAD 5.45)</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Cash: <u>N/A.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Securities
 (including options, warrants etc.) and dollar value: <u>355,584 Subordinate Voting Shares</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Other: <u>N/A.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Expiry
 date of options, warrants, etc. if any: <u>N/A.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Exercise
 price of options, warrants, etc. if any: <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Work
 commitments: <u>N/A</u>.

4. State
 how the purchase or sale price was determined (e.g. arm's-length negotiation, independent
 committee of the Board, third party valuation etc).

<u>The purchase price was determined through arm's length negotiation.</u>

5. Provide
 details of any appraisal or valuation of the subject of the acquisition known to management
 of the Issuer: <u>N/A</u>.

6. The names of parties receiving securities
 of the Issuer pursuant to the acquisition and the number of securities to be issued are described
 as follows:

7. ---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Name of Party<br> (If not an<br> individual,<br> name all <br> insiders of the<br> Party)** | &nbsp;&nbsp;**Number<br> and Type of<br> Securities <br> to be <br> Issued** | &nbsp;&nbsp;**Dollar<br> value per<br> Security** | &nbsp;&nbsp;**Conversion<br> price (if<br> applicable)** | &nbsp;&nbsp;**Prospectus <br> Exemption** | &nbsp;&nbsp;**Describe<br> relationship <br> to Issuer<sup>(1)</sup>** |
| &nbsp;&nbsp;HMS Trust A, dated February 28, 2017 | &nbsp;&nbsp;177792 | &nbsp;&nbsp;5.45 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;Accredited Investor Exemption &nbsp;&nbsp;Nil | &nbsp;&nbsp;Not a Related Person |
| &nbsp;&nbsp;HMS Trust B, dated February 28, 2017 | &nbsp;&nbsp;177792 | &nbsp;&nbsp;5.45 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;Accredited Investor Exemption &nbsp;&nbsp;Nil | &nbsp;&nbsp;Not a Related Person |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Indicate
 if Related Person

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 6 |

---

8. Details of the steps taken by the Issuer to
 ensure that the vendor has good title to the assets being acquired: <u>Customary due diligence, including lien, litigation and corporate due diligence as customary under local law.</u> 

9. Provide the following
 information for any agent's fee, commission, bonus or finder's fee, or other
 compensation paid or to be paid in connection with the acquisition (including warrants, options,
 etc.):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Details
 of any dealer, agent, broker or other person receiving compensation in connection with the
 acquisition (name, and if a corporation, identify persons owning or exercising voting control
 over 20% or more of the voting shares if known to the Issuer): <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Cash <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Securities <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Other <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Expiry
 date of any options, warrants etc. <u>N/A</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Exercise price of any options, warrants etc. <u>N/A</u>.

10. State whether the sales agent, broker or other person receiving compensation in connection with
 the acquisition is a Related Person or has any other relationship with the Issuer and provide details
 of the relationship. <u>N/A</u> 

11. If applicable, indicate whether the acquisition
 is the acquisition of an interest in property contiguous to or otherwise related to any other
 asset acquired in the last 12 months. <u>N/A</u>.

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 7 |

---

**Certificate Of Compliance**

The undersigned hereby certifies that:

1. The undersigned is a director and/or senior officer of the Issuer and
 has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate
 of Compliance on behalf of the Issuer.

2. As of the date hereof there is not material information concerning the
 Issuer which has not been publicly disclosed.

3. the Issuer has obtained the express written consent of each applicable individual to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the disclosure of their information to the Exchange pursuant to
 this Form or otherwise pursuant to this filing; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the collection, use and disclosure of
 their information by the Exchange in the manner and for the purposes described in Appendix
 A or as otherwise identified by the Exchange, from time to time

4. The undersigned hereby certifies to the Exchange that the Issuer is
 in compliance with the requirements of applicable securities legislation (as such term is defined in
 National Instrument 14-101) and all Exchange Requirements (as defined in CSE Policy 1).

5. All of the information in this Form 9 Notice of Issuance of Securities
 is true.

Dated <u>January 5, 2022</u>.

---

| |
|:---|
| Peter Clateman |
| Name of Director or Senior Officer |
| (signed) Peter Clateman |
| Signature |
| Chief Legal Officer |
| Official Capacity |

---

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 1 |

---

**Appendix A**

**PERSONAL INFORMATION COLLECTION POLICY REGARDING FORM 9**

The Canadian Securities Exchange and its subsidiaries, affiliates, regulators and agents (collectively, "CSE or the "Exchange") collect and use the information (which may include personal or other information) which has been provided in Form 9 for the following purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· To
 determine whether an individual is suitable to be associated with a Listed Issuer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· To
 determine whether an issuer is suitable for listing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· To
 determine whether allowing an issuer to be listed or allowing an individual to be associated
 with a Listed Issuer could give rise to investor protection concerns or could bring the Exchange
 into disrepute;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· To
 conduct enforcement proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· To
 ensure compliance with Exchange Requirements and applicable securities legislation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· To
 fulfil the Exchange's obligation to regulate its marketplace.

The CSE also collects information, including personal information, from other sources, including but not limited to securities regulatory authorities, law enforcement and self-regulatory authorities, regulation service providers and their subsidiaries, affiliates, regulators and agents. The Exchange may disclose personal information to these entities or otherwise as provided by law and they may use it for their own investigations.

The Exchange may use third parties to process information or provide other administrative services. Any third party will be obliged to adhere to the security and confidentiality provisions set out in this policy.

All personal information provided to or collected by or on behalf of The Exchange and that is retained by The Exchange is kept in a secure environment. Only those employees who need to know the information for the purposes listed above are permitted access to the information or any summary thereof. Employees are instructed to keep the information confidential at all times.

Information about you that is retained by the Exchange and that you have identified as inaccurate or obsolete will be corrected or removed.

If you wish to consult your file or have any questions about this policy or our practices, please write the Chief Privacy Officer, Canadian Securities Exchange, 220 Bay Street – 9th Floor, Toronto, ON, M5J 2W4.

---

| |
|:---|
| **FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF** |
| **LISTED SECURITIES** |
| September 2018 |
| Page 1 |

---

## Exhibit 99.2

**Exhibit 99.2**

**FORM 7<br><u>MONTHLY PROGRESS REPORT</u>**

Name of Listed Issuer: Curaleaf Holdings, Inc. (the "**Issuer**" or "**Curaleaf**").

Trading Symbol: CURA

Number of Outstanding Listed Securities: 623,377,025

Date: January 8, 2023

This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer's obligation to separately report material information forthwith upon the information becoming known to management or to post the forms required by Exchange Policies. If material information became known and was reported during the preceding month to which this report relates, this report should refer to the material information, the news release date and the posting date on the Exchange website.

This report is intended to keep investors and the market informed of the Issuer's ongoing business and management activities that occurred during the preceding month. Do not discuss goals or future plans unless they have crystallized to the point that they are "material information" as defined in the Policies. The discussion in this report must be factual, balanced and non-promotional.

**General Instructions**

(a) Prepare this Monthly Progress Report using the format set out below. The sequence of questions must not
be altered, nor should questions be omitted or left unanswered. The answers to the items must be in narrative form. State when the answer
to any item is negative or not applicable to the Issuer. The title to each item must precede the answer.

(b) The term "Issuer" includes the Issuer and any of its subsidiaries.

(c) Terms used and not defined in this form are defined or interpreted in Policy 1 – Interpretation and General Provisions.

**Report on Business**

1. Provide a general overview and discussion of the development of the Issuer's business and operations
over the previous month. Where the Issuer was inactive disclose this fact.

**<u>General</u>**

Curaleaf Holdings, Inc. ("**Curaleaf**" or the "**Company**") operates as a life science company developing full scale cannabis operations, with core competencies in cultivation, manufacturing, dispensing and medical cannabis research. Curaleaf is a leading vertically integrated medical and wellness cannabis operator in the United States. As of December 31, 2022, the Company has operations in 21 states including operating 145 dispensaries and 29 cultivation sites with a focus on highly populated states including Arizona, Florida, Illinois, Massachusetts, New York, New Jersey and Pennsylvania. The Company leverages its extensive research and development capabilities to distribute cannabis products with the highest standard for safety, effectiveness, consistent quality and customer care. The Company is committed to leading the industry in education and advancement through research and advocacy. The Company markets to medical and adult-use customers through brand strategies intended to build trust and loyalty. Moreover, Curaleaf International Holdings Limited, a subsidiary of the Issuer, is the largest vertically integrated independent cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with leading cultivation, extraction and production capabilities.

**<u>Recent developments regarding the Issuer's business and operations</u>**

On December 7, 2022, Curaleaf announced a first-of-its-kind cannabis education partnership for its Grassroots brand with Ganjier, the Cannabis Sommelier Certification Program.

Please see the Issuer's press release dated December 7, 2022, filed on the Issuer's website for more information.

On December 13, 2022, Curaleaf announced its Select brand made available its third "The Farmer's Select" program across California in partnership with Autumn Brands.

Please see the Issuer's press release dated December 13, 2022, filed on the Issuer's website for more information.

On December 19, 2022, Curaleaf announced the addition of two new members to its Board of Directors, effective December 31, 2022.

Please see the Issuer's press release dated December 19, 2022, filed on the Issuer's website for more information and available under the Issuer's SEDAR profile at www.sedar.com.

On December 20, 2022, Curaleaf opened a new dispensary in Tallahassee, Florida.

Please see the Issuer's press release dated December 20, 2022, filed on the Issuer's website for more information.

2. Provide a general overview and discussion of the activities of management.

Boris Jordan, Executive Chairman, was quoted on CNBC on 12/23/22 in a story titled, "Marijuana's black market is undercutting legal businesses." His statements about SAFE Banking were also included in Hemp Gazette on 12/22/22 and The Hill on 12/21/22, Common Dreams on 12/20/22, MJ Biz Daily on 12/19/22 and Benzinga on 12/15/22 and 12/26/22.

Matt Darin, CEO, spoke to The Las Vegas Sun for a story on 12/20/22 titled, "Cannabis lounges are coming to Nevada; what will they look like?" He also spoke with Bloomberg for a story on 12/16/22 titled, "New York Weed Is One Thing That's Cheaper These Days." On 12/6/22, Mr. Darin spoke at Cowen's 5th Annual Cannabis Conference in a fireside chat with Vivien Azer, Managing Director at Cowen. On 12/7/22, he also participated in a lunch panel with Andrew Partheniou, Vice President at Stifel at Stifel Canada's 3rd Annual Future of Healthcare Conference.

3. Describe and provide details of any new products or services developed or offered. For resource companies,
provide details of new drilling, exploration or production programs and acquisitions of any new properties and attach any mineral or oil
and gas or other reports required under Ontario securities law.

On December 7, 2022, Curaleaf announced a first-of-its-kind cannabis education partnership for its Grassroots brand with Ganjier, the Cannabis Sommelier Certification Program.

Please see the Issuer's press release dated December 7, 2022, filed on the Issuer's website for more information.

4. Describe and provide details of any products or services that were discontinued. For resource companies,
provide details of any drilling, exploration or production programs that have been amended or abandoned.

N/A

5. Describe any new business relationships entered into between the Issuer, the Issuer's affiliates
or third parties including contracts to supply products or services, joint venture agreements and licensing agreements etc. State whether
the relationship is with a Related Person of the Issuer and provide details of the relationship.

N/A

6. Describe the expiry or termination of any contracts or agreements between the Issuer, the Issuer's
affiliates or third parties or cancellation of any financing arrangements that have been previously announced.

N/A

7. Describe any acquisitions by the Issuer or dispositions of the Issuer's assets that occurred during
the preceding month. Provide details of the nature of the assets acquired or disposed of and provide details of the consideration paid
or payable together with a schedule of payments if applicable, and of any valuation. State how the consideration was determined and whether
the acquisition was from, or the disposition was to, a Related Person of the Issuer and provide details of the relationship.

N/A

8. Describe the acquisition of new customers or loss of customers.

Please see Item 1 for new dispensary openings during the month of December.

9. Describe any new developments or effects on intangible products such as brand names, circulation lists,
copyrights, franchises, licenses, patents, software, subscription lists and trademarks.

N/A

10. Report on any employee hirings, terminations or lay-offs with details of anticipated length of lay-offs.

 

As of December 31, 2022, the Issuer had a total of 5,952 employees, which includes 157 new hires and 241 terminations in the month of December.

11. Report on any labour disputes and resolutions of those disputes if applicable.

N/A

12. Describe and provide details of legal proceedings to which the Issuer became a party, including the name
of the court or agency, the date instituted, the principal parties to the proceedings, the nature of the claim, the amount claimed, if
any, if the proceedings are being contested, and the present status of the.

Curaleaf may become threatened by a party, or otherwise become party to litigation from time to time in the ordinary course of business which could adversely affect its business.

**<u>Sentia Wellness</u>**

*Measure 8 Ventures LP et al. v. Khanna et al.,* Or. No. 22CV00946

No updates since last reporting on the Form 7 filed on December 6, 2022.

13. Provide details of any indebtedness incurred or repaid by the Issuer together with the terms of such indebtedness.

N/A

14. Provide details of any securities issued and options or warrants granted

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Security** | &nbsp;&nbsp;**Number Issued** | &nbsp;&nbsp;**Details of Issuance** | &nbsp;&nbsp;**Use of Proceeds<sup>(1)</sup>** |
| &nbsp;&nbsp;Subordinate Voting Shares | &nbsp;&nbsp;141713 | &nbsp;&nbsp;Shares issued in connection with RSU conversions and option exercises during the month of December 2022. | &nbsp;&nbsp;The proceeds from payment of the exercise/conversion price will be used for general working capital purposes. |

---

&nbsp;&nbsp;&nbsp;&nbsp;*(1)* *State aggregate proceeds and intended allocation of proceeds.* 

 

15. Provide details of any loans to or by Related Persons.

N/A

16. Provide details of any changes in directors, officers or committee members.

On December 19, 2022, Curaleaf announced the addition of Shasheen Shah and Michelle Bodner to its Board of Directors, effective December 31, 2022.

Please see the Issuer's press release dated December 19, 2022, filed on the Issuer's website for more information.

17. Discuss any trends which are likely to impact the Issuer including trends in the Issuer's market(s)
or political/regulatory trends.

N/A

This document contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", " or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this Monthly Progress Report contains forward-looking statements and information concerning (i) the expected benefits of recently opened dispensaries, new cannabis education program partnership and Select brand expansion and (ii) the Issuer's current litigation and arbitration proceedings. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the Issuer with respect to the matter described in this Monthly Progress Report. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this Monthly Progress Report and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under the "Risk Factors" heading in the Issuer's management's discussion and analysis for the year ended December 31, 2021 and under the "Risk Factors" heading in the Issuer's annual information form for the year ended December 31, 2021, and in other filings that the Company has made and may make in the future with the Canadian securities regulatory authorities available on SEDAR under the Issuer's profile at www.sedar.com or with the U.S. Securities and Exchange Commission available at www.sec.gov/edgar. Forward-looking statements contained herein are made only as to the date of this Monthly Progress Report and the Issuer undertakes no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The Issuer cautions investors not to place undue reliance on the forward-looking statements contained in this Monthly Progress Report.

 ****

***[signature page follows]***

**Certificate of Compliance**

The undersigned hereby certifies that:

1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution
of the board of directors of the Issuer to sign this Certificate of Compliance.

2. As of the date hereof there is no material information concerning the Issuer which has not been publicly
disclosed.

3. The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements
of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined
in CNSX Policy 1).

4. All of the information in this Form 7 Monthly Progress Report is true.

Dated: January 8, 2023

---

| |
|:---|
| Peter Clateman |
| Name of Director or Senior Officer |
| /s/ Peter Clateman |
| Signature |
| Chief Legal Officer |
| Official Capacity |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; ***Issuer Details***<br> Name of Issuer<br> Curaleaf Holdings, Inc. | &nbsp;&nbsp; For Month Ended<br> December 31, 2022 | &nbsp;&nbsp; Date of Report<br> YY/MM/DD<br> January 8, 2023 |
| &nbsp;&nbsp; Issuer Address<br> 301 Edgewater Place | &nbsp;&nbsp; Issuer Address<br> 301 Edgewater Place | &nbsp;&nbsp; Issuer Address<br> 301 Edgewater Place |
| &nbsp;&nbsp; City/Province/Postal Code <br> Wakefield, MA 01880 USA | &nbsp;&nbsp; Issuer Fax No.<br> N/A | &nbsp;&nbsp; Issuer Telephone No.<br> (781) 451-0150 |
| &nbsp;&nbsp; Contact Name<br> Investor Relations<br>| &nbsp;&nbsp; Contact Position<br> Investor Relations<br>| &nbsp;&nbsp; Contact Telephone No.<br> (781) 451-0150 |
| &nbsp;&nbsp; Contact Email Address<br> IR@curaleaf.com<br>| &nbsp;&nbsp; Web Site Address<br> <u>www.curaleaf.com</u> | &nbsp;&nbsp; Web Site Address<br> <u>www.curaleaf.com</u> |

---

## Exhibit 99.3

**Exhibit 99.3**

**FORM 6**

**<u>CERTIFICATE OF COMPLIANCE</u>**

**TO: CANADIAN SECURITIES EXCHANGE (the "CSE")**

Curaleaf Holdings, Inc. (the "**Listed Issuer**") hereby certifies to the CSE that the Listed Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in Policy 1).

---

| | |
|:---|:---|
| Date: | January 9, 2023 |
| Signed: | *(signed) "Peter Clateman"* |
|  | (Signature) |
|  | Peter Clateman |
|  | (Print Name) |
|  | Chief Legal Officer |
|  | (Print Office) |

---

**FORM 6 – CERTIFICATE OF COMPLIANCE**

January 2015

## Exhibit 99.4

**Exhibit 99.4**

**FORM 9**

**<u>NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES</u>**

**<u>(or securities convertible or exchangeable into listed securities</u>**<sup>1</sup>**<u>)</u>**

Name of Listed Issuer: Symbol(s): <br> Curaleaf Holdings, Inc. (the "Issuer"). <u>CURA</u>

Date: <u>January 10, 2023</u> Is this an updating or amending Notice: ⌧Yes ◻No

If yes provide date(s) of prior Notices: <u>Jul 26, 2019; Jul 7, 2020; Jul 30, 2020; Nov 2, 2022</u>.

Issued and Outstanding Securities of Issuer Prior to Issuance: <u>619,688,548 Subordinate Voting Shares</u>.

**Pricing**

Date of news release announcing proposed issuance: <u>N/A</u> or

Date of confidential request for price protection: <u>N/A</u>

Closing Market Price on Day Preceding the news release: <u>N/A</u> or

Day preceding request for price protection: <u>N/A</u>

**Closing**

Number of securities to be issued: <u>3,483,581 Subordinate Voting Shares.</u>

Issued and outstanding securities following issuance: <u>623,172,129 Subordinate Voting Shares.</u>

**Instructions:**

&nbsp;&nbsp;&nbsp;&nbsp;1. For
 private placements (including debt settlement), complete tables 1A and 1B in Part 1 of this
 form.

&nbsp;&nbsp;&nbsp;&nbsp;2. Complete
 Table 1A – Summary for all purchasers, excluding those identified in Item 8.

&nbsp;&nbsp;&nbsp;&nbsp;3. Complete
 Table 1B – Related Persons only for Related Persons

&nbsp;&nbsp;&nbsp;&nbsp;4. If
 shares are being issued in connection with an acquisition (either as consideration or to
 raise funds for a cash acquisition) please proceed to Part 2 of this form.

&nbsp;&nbsp;&nbsp;&nbsp;5. An
 issuance of non-convertible debt does not have to be reported unless it is a significant
 transaction as defined in Policy 7, in which case it is to be reported on Form 10 –
 Notice of Proposed Transaction

**6.** Post the completed Form 9 to the CSE website in accordance with *Policy 6 – Distributions.* In addition, the completed form must be delivered to <u>listings@thecse.com</u> with an appendix that includes the information in Table 1B for ALL placees.

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | |
|:---|:---|
| **Part 1.** | **Private Placement** |

---

**<u>Table 1A – Summary</u>**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;Each jurisdiction in which purchasers reside | &nbsp;&nbsp;Number of Purchasers | &nbsp;&nbsp;Price per Security | &nbsp;&nbsp;Total dollar value<br> (CDN$) raised in <br> the jurisdiction |
| &nbsp;&nbsp;Total number of purchasers: |  |  |  |
| &nbsp;&nbsp;Total dollar value of distribution in all jurisdictions: | &nbsp;&nbsp;Total dollar value of distribution in all jurisdictions: | &nbsp;&nbsp;Total dollar value of distribution in all jurisdictions: |  |

---

**<u>Table 1B – Related Persons</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;<br> **Full Name<br> & Municipality<br> of Residence<br> of Placee** | &nbsp;&nbsp;<br> **Number of<br> Securities<br> Purchased<br> or to be<br> Purchased** | &nbsp;&nbsp;<br> **Purchase<br> price per<br> Security<br> (CDN$)** | &nbsp;&nbsp;<br> **Conversion**<br>**Price<br> (if Applicable)<br> (CDN$)** | &nbsp;&nbsp;<br> **Prospectus<br> Exemption** | &nbsp;&nbsp;<br> **Total Securities<br> Previously <br> Owned, <br> Controlled or <br> Directed** | &nbsp;&nbsp;<br> **Payment<br> Date(1)** | &nbsp;&nbsp;<br> **Describe<br> relationship to<br> Issuer (2)** |

---

<sup>1</sup>An issuance of non-convertible debt does not have to be reported unless it is a significant transaction as defined in Policy 7, in which case it is to be reported on Form 10.

1. Total amount
 of funds to be raised: <u> </u>.

2. Provide
 full details of the use of the proceeds. The disclosure should be sufficiently complete to
 enable a reader to appreciate the significance of the transaction without reference to any
 other material. <u>.</u> 

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

3. Provide
 particulars of any proceeds which are to be paid to Related Persons of the Issuer: <u>.</u> 

4. If
 securities are issued in forgiveness of indebtedness, provide details of the debt agreement(s)
 or and the agreement to exchange the debt for securities.

5. Description
 of securities to be issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Class .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Number .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Price
 per security .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Voting rights

6. Provide
 the following information if warrants, (options) or other convertible securities are to be
 issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Number .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Number of securities eligible to be purchased on exercise of warrants (or options) <u> </u>.

(c) Exercise price .

(d) Expiry date .

7. Provide
 the following information if debt securities are to be issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Aggregate principal amount .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Maturity date .

(c) Interest rate .

(d) Conversion terms .

(e) Default provisions .

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

8. Provide
 the following information for any agent's fee, commission, bonus or finder's
 fee, or other compensation paid or to be paid in connection with the placement (including
 warrants, options, etc.):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Details
 of any dealer, agent, broker or other person receiving compensation in connection with the
 placement (name, and if a corporation, identify persons owning or exercising voting control
 over 20% or more of the voting shares if known to the Issuer): <u> </u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Cash .

(c) Securities .

(d) Other .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Expiry date of any options, warrants etc. .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Exercise price of any options, warrants etc. .

9. State
 whether the sales agent, broker, dealer or other person receiving compensation in connection
 with the placement is Related Person or has any other relationship with the Issuer and provide
 details of the relationship <u>.</u> 

10. Describe any unusual particulars of the transaction (i.e. tax "flow through" shares, etc.). <br><u>.</u>

11. State whether the private placement will result in a change of control. <br><u>.</u>

12. Where
 there is a change in the control of the Issuer resulting from the issuance of the private
 placement shares, indicate the names of the new controlling shareholders. <u>.</u> 

13. Each
 purchaser has been advised of the applicable securities legislation restricted or seasoning
 period. All certificates for securities issued which are subject to a hold period bear the
 appropriate legend restricting their transfer until the expiry of the applicable hold period
 required by National Instrument 45-102 Resale of Securities.

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | |
|:---|:---|
| **Part 2.** | **Acquisition** |

---

***This Form 9 amends and restates the Form 9<br> filed by the Issuer on November 2, 2022.***

1. Provide
 details of the assets to be acquired by the Issuer (including the location of the assets,
 if applicable). The disclosure should be sufficiently complete to enable a reader to appreciate
 the significance of the transaction without reference to any other material:

<u>On July 17, 2019, the Issuer announced it had signed a definitive merger agreement (the "**Merger Agreement**") to acquire GR Companies Inc. ("**Grassroots**") (the "**Grassroots Transaction**"). On June 22, 2020, the Issuer entered into an Amended and Restated Agreement and Plan of Merger (the "**A&R Merger Agreement**") which amended and restated the Merger Agreement and amended certain terms of the Grassroots Transaction. The Grassroots Transaction closed on June 23, 2020. Refer to the CSE Form 9 dated June 30, 2020 for a detailed description of the consideration paid on the closing of the Grassroots Transaction (the "**Closing**").</u> 

<u>Under the A&R Merger Agreement, if certain designated dispensaries which were under contract to be sold to a third party following the Closing remained unsold as of the 24-month anniversary of the Closing, the securityholders of Grassroots (the "**Participating Securityholders**") had the right (but not the obligation) to request the payment of either (i) subordinate voting shares of the Issuer ("**Subordinate Voting Shares**") having an aggregate value of USD 30 million (the "**Share Consideration**"), or (ii) USD 25 million in cash (the "**Cash Consideration**"), but not a combination thereof, in exchange for the extinguishment of the right of the Participating Securityholders to receive additional contingent consideration upon the sale of the designated dispensaries in accordance with the A&R Merger Agreement.</u> 

<u>On September 14, 2022, the Issuer and GR Shareholder Representative, LLC, a Delaware limited liability company, solely in its capacity as the shareholder representative, agent and attorney-in-fact of the Participating Securityholders (the "**Seller Representative**"), agreed to further modify the A&R Merger Agreement to give each Participating Securityholder the right to elect to receive their pro rata portion of the Cash Consideration or the Share Consideration in connection with the exercise of the request for payment described above.</u> 

<u>As the designated dispensaries remained unsold as of June 23, 2022, the Seller Representative exercised its right, on October 14, 2022, to request payment from the Company in accordance with the A&R Merger Agreement, as modified. Such payment is expected to be paid on November 3, 2022, and the Issuer's obligation towards the Participating Securityholders expected to be fulfilled by (i) paying approximately USD 8.58 million (equivalent to approximately CAD 11.7 million using the daily average exchange rate of CAD 1.3649 to USD 1.00 published by the Bank of Canada on October 31, 2022) in cash to certain Participating Securityholders who elected to receive their pro rata portion of the Cash Consideration, and (ii) issuing 3,483,581 Subordinate Voting Shares to certain Participating Securityholders who elected to receive their pro rata portion of the Share Consideration, having an aggregate value of approximately CAD 27.1 million based on the 30-day VWAP of the Subordinate Voting Shares on the CSE as of October 13, 2022, being $7.7836.</u>

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

2. Provide
 details of the acquisition including the date, parties to and type of agreement (eg: sale,
 option, license etc.) and relationship to the Issuer. The disclosure should be sufficiently
 complete to enable a reader to appreciate the significance of the acquisition without reference
 to any other material:

<u>Please refer to Section 1 immediately above.</u> 

3. Provide
 the following information in relation to the total consideration for the acquisition (including
 details of all cash, securities or other consideration) and any required work commitments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Total
 aggregate consideration in Canadian dollars: <u>Approximately CAD 38.8 million (equivalent to approximately USD 28.4 million)</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Cash: <u>USD 8.58 million.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Securities
 (including options, warrants etc.) and dollar value: <u>3,483,581 Subordinate Voting Shares, having an aggregate value of approximately CAD 27.1 million</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Other: <u>N/A.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Expiry
 date of options, warrants, etc. if any: <u>N/A.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Exercise
 price of options, warrants, etc. if any: <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Work
 commitments: <u>N/A</u>.

4. State
 how the purchase or sale price was determined (e.g. arm's-length negotiation, independent
 committee of the Board, third party valuation etc).

<u>The purchase price was determined through arm's length negotiation.</u>

5. Provide
 details of any appraisal or valuation of the subject of the acquisition known to management
 of the Issuer: <u>N/A</u>.

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

6. The names of parties receiving securities of the Issuer pursuant to the acquisition and the number of
securities to be issued are described as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Name of Party <br> (If not an <br> individual, <br> name all <br> insiders of the<br> Party)** | &nbsp;&nbsp; **Number <br> and Type of<br> Securities<br> to be<br> Issued** | &nbsp;&nbsp; **Dollar<br> value per<br> Security**<br> **(CAD)**  | &nbsp;&nbsp; **Conversion <br> price (if<br> applicable)** | &nbsp;&nbsp; **Prospectus<br> Exemption** | &nbsp;&nbsp; **Total <br> Securities,<br> Previously<br> Owned, <br> Controlled or<br> Directed by <br> Party** | &nbsp;&nbsp; **Describe<br> relationship** <br> **to Issuer<sup>(1)</sup>** |
| &nbsp;&nbsp;Refer to Exhibit 1 attached hereto. | &nbsp;&nbsp;3,483,581 Subordinate Voting Shares in the aggregate. | &nbsp;&nbsp;7.78 | &nbsp;&nbsp;N/A | &nbsp;&nbsp; Section 2.11 (*Business Combination & Reorganization*) of National Instrument 45-106<br>| &nbsp;&nbsp;Not available. | &nbsp;&nbsp;Not a Related Person other than those identified by the symbol \*\* in Exhibit 1 attached hereto. |

---

(1) Indicate if Related Person

7. Details of the steps taken by the Issuer to ensure that the vendor has good title to the assets being
acquired: <u>Customary due diligence, including lien and litigation due diligence as customary under local law.</u> 

8. Provide the following information for any agent's fee, commission, bonus or finder's fee,
or other compensation paid or to be paid in connection with the acquisition (including warrants, options, etc.):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Details of any dealer, agent, broker or other person receiving compensation in connection with the acquisition
(name, and if a corporation, identify persons owning or exercising voting control over 20% or more of the voting shares if known to the
Issuer): <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Cash <u>N/A</u>.

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Securities <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Other <u>N/A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Expiry date of any options, warrants etc. <u>N/A</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Exercise price of any options, warrants etc. <u>N/A</u>.

9. State whether the sales agent, broker or other person receiving compensation in connection with the acquisition is a Related Person
or has any other relationship with the Issuer and provide details of the relationship. <u>N/A</u> 

10. If applicable, indicate whether the acquisition is the acquisition of an interest in property contiguous
to or otherwise related to any other asset acquired in the last 12 months. <u>N/A</u>.

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

**Certificate Of Compliance**

The undersigned hereby certifies that:

1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution
of the board of directors of the Issuer to sign this Certificate of Compliance on behalf of the Issuer.

2. As of the date hereof there is not material information concerning the Issuer which has not been publicly
disclosed.

3. the Issuer has obtained the express written consent of each applicable individual to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the disclosure of their information to the Exchange pursuant to this Form or otherwise pursuant to this filing; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the collection, use and disclosure of their information by the Exchange in the manner and for the purposes
described in Appendix A or as otherwise identified by the Exchange, from time to time

4. The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements
of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined
in CSE Policy 1).

5. All of the information in this Form 9 Notice of Issuance of Securities is true.

Dated <u>January 10, 2023.</u>

---

| |
|:---|
| Peter Clateman |
| Name of Director or Senior Officer |
| (signed) Peter Clateman |
| Signature |
| Chief Legal Officer |
| Official Capacity |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

**Appendix A**

**PERSONAL INFORMATION COLLECTION POLICY REGARDING FORM 9**

The Canadian Securities Exchange and its subsidiaries, affiliates, regulators and agents (collectively, "CSE or the "Exchange") collect and use the information (which may include personal or other information) which has been provided in Form 9 for the following purposes:

• To determine whether an individual is suitable to be associated with a Listed Issuer;

• To determine whether an issuer is suitable for listing;

• To determine whether allowing an issuer to be listed or allowing an individual to be associated with a
Listed Issuer could give rise to investor protection concerns or could bring the Exchange into disrepute;

• To conduct enforcement proceedings;

• To ensure compliance with Exchange Requirements and applicable securities legislation; and

• To fulfil the Exchange's obligation to regulate its marketplace.

The CSE also collects information, including personal information, from other sources, including but not limited to securities regulatory authorities, law enforcement and self-regulatory authorities, regulation service providers and their subsidiaries, affiliates, regulators and agents. The Exchange may disclose personal information to these entities or otherwise as provided by law and they may use it for their own investigations.

The Exchange may use third parties to process information or provide other administrative services. Any third party will be obliged to adhere to the security and confidentiality provisions set out in this policy.

All personal information provided to or collected by or on behalf of The Exchange and that is retained by The Exchange is kept in a secure environment. Only those employees who need to know the information for the purposes listed above are permitted access to the information or any summary thereof. Employees are instructed to keep the information confidential at all times.

Information about you that is retained by the Exchange and that you have identified as inaccurate or obsolete will be corrected or removed.

If you wish to consult your file or have any questions about this policy or our practices, please write the Chief Privacy Officer, Canadian Securities Exchange, 220 Bay Street – 9th Floor, Toronto, ON, M5J 2W4.

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

**Exhibit 1**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**No.** | **Name of Party** | **Number of Subordinate <br> Voting Shares to be Issued** |
| &nbsp;&nbsp;1. | SCM INVESTMENTS LP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1055 |
| &nbsp;&nbsp;2. | BRIAN T SCHINDERLE TR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31941 |
| &nbsp;&nbsp;3. | AES INVESTMENTS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13361 |
| &nbsp;&nbsp;4. | RAHUL BAJAJ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1587 |
| &nbsp;&nbsp;5. | BDOG LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2259 |
| &nbsp;&nbsp;6. | JONATHAN BERGER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;7. | WREN BERGER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1996 |
| &nbsp;&nbsp;8. | BRET BONNET | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13472 |
| &nbsp;&nbsp;9. | SEAN D BOSSY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;909 |
| &nbsp;&nbsp;10. | CARL BOYAR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7974 |
| &nbsp;&nbsp;11. | NANCY J BOYAR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2516 |
| &nbsp;&nbsp;12. | 2655137 ONTARIO INC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1322 |
| &nbsp;&nbsp;13. | DAVID BROWN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;376 |
| &nbsp;&nbsp;14. | BUDDY FINANCE LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17120 |
| &nbsp;&nbsp;15. | JUN CHIN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;16. | ANDREW COHEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23047 |
| &nbsp;&nbsp;17. | GEOFFREY R CUBITT & KATHERINE C CUBITT | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5274 |
| &nbsp;&nbsp;18. | MATTHEW DARIN \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9722 |
| &nbsp;&nbsp;19. | DAVID PEPPER & | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2259 |
| &nbsp;&nbsp;20. | KATHERINE DAVISSON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;529 |
| &nbsp;&nbsp;21. | ANTHONY DEPALO | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3702 |
| &nbsp;&nbsp;22. | DIENER FRIEDLANDER LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2259 |
| &nbsp;&nbsp;23. | DL GREEN HOLDINGS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9093 |
| &nbsp;&nbsp;24. | PHILIP M DUTTON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;25. | EISENBERG FAMILY INVESTORS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14791 |
| &nbsp;&nbsp;26. | EJJ CAPITAL LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2645 |
| &nbsp;&nbsp;27. | MARC TOBIN ESRIG | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;190 |
| &nbsp;&nbsp;28. | FIDELITY CLEARING CANADA ULC TR 2613032 ONTARIO INC A/C E5D ANAC B | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1322 |
| &nbsp;&nbsp;29. | FREDERICK L FISCHER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6777 |
| &nbsp;&nbsp;30. | FORTEZZA INVESTMENTS LP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5289 |
| &nbsp;&nbsp;31. | G CUBED INVESTMENTS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5896 |
| &nbsp;&nbsp;32. | GARPA INVESTMENTS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2445 |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**No.** | **Name of Party** | **Number of Subordinate <br> Voting Shares to be Issued** |
| &nbsp;&nbsp;33. | KIBIBI A M GAUGHAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9806 |
| &nbsp;&nbsp;34. | GB PORTFOLIO INVESTMENTS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;410730 |
| &nbsp;&nbsp;35. | JEFFREY GLAZER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1736 |
| &nbsp;&nbsp;36. | LISA GLAZER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1736 |
| &nbsp;&nbsp;37. | MARC GORDON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3382 |
| &nbsp;&nbsp;38. | GREAT POINT HOLDINGS 2018 LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;906 |
| &nbsp;&nbsp;39. | GREEN HORNET LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;140059 |
| &nbsp;&nbsp;40. | RONNIE GREISSMAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1807 |
| &nbsp;&nbsp;41. | BRENT GUSTAF | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;451 |
| &nbsp;&nbsp;42. | HARPUA ENTERPRISES LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;893 |
| &nbsp;&nbsp;43. | HINSDALE LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3173 |
| &nbsp;&nbsp;44. | GRAHAM HUGHSON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;293 |
| &nbsp;&nbsp;45. | PEYTON HURST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2523 |
| &nbsp;&nbsp;46. | ITEXT VENTURES LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1258 |
| &nbsp;&nbsp;47. | JAMA HOLDINGS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41134 |
| &nbsp;&nbsp;48. | JILL GOLDFINE MEISTER TR JILL AND PAUL MEISTER EXEMPT CHILDREN'S TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1044 |
| &nbsp;&nbsp;49. | BRUCE KAPLAN & KAROL KAPLAN JT TEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;939 |
| &nbsp;&nbsp;50. | TROY KAPLAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6053 |
| &nbsp;&nbsp;51. | JEFFREY B KATZ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15433 |
| &nbsp;&nbsp;52. | ROBERT KEMP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23706 |
| &nbsp;&nbsp;53. | PERRINE KNIGHT | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13488 |
| &nbsp;&nbsp;54. | ANITA KOSIR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;529 |
| &nbsp;&nbsp;55. | ANTE KOSIR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4044 |
| &nbsp;&nbsp;56. | JEFFREY KRAMER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2837 |
| &nbsp;&nbsp;57. | ROY LANDGREN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19923 |
| &nbsp;&nbsp;58. | LAWRENCE KEMPLER ENTERPRISES LP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2110 |
| &nbsp;&nbsp;59. | LDW LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8194 |
| &nbsp;&nbsp;60. | STEVEN LEVINE | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;61. | LOUIS LEVINSON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7606 |
| &nbsp;&nbsp;62. | LOWER ELECTRIC LLC CASH BALANCE PLAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2321 |
| &nbsp;&nbsp;63. | LR FAMILY EQUITIES LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3120 |
| &nbsp;&nbsp;64. | MAD INVESTORS GR LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;331367 |
| &nbsp;&nbsp;65. | MAD INVESTORS GRMD LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10046 |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**No.** | **Name of Party** | **Number of Subordinate <br> Voting Shares to be Issued** |
| &nbsp;&nbsp;66. | MAD INVESTORS GRPA LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19215 |
| &nbsp;&nbsp;67. | MARSHFIELD DEVELOPMENT LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2719 |
| &nbsp;&nbsp;68. | MEASURE 8 CANADA FULL SPECTRUM FUND LP \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8879 |
| &nbsp;&nbsp;69. | MEASURE 8 VENTURES LP \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;135891 |
| &nbsp;&nbsp;70. | RICHARD MEREL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19695 |
| &nbsp;&nbsp;71. | GLEN MESAROS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9806 |
| &nbsp;&nbsp;72. | EUGENE D MINSKY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1055 |
| &nbsp;&nbsp;73. | MITC HOLDINGS INC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8923 |
| &nbsp;&nbsp;74. | BRIAN MITCHELL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2637 |
| &nbsp;&nbsp;75. | JUANITA MONTALVO | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;529 |
| &nbsp;&nbsp;76. | TRAVIS MOYER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7276 |
| &nbsp;&nbsp;77. | NAVARONEG2 LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5289 |
| &nbsp;&nbsp;78. | NAVIGAME INC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2516 |
| &nbsp;&nbsp;79. | NLS INVESTMENT PARTNERS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7548 |
| &nbsp;&nbsp;80. | NRH INVESTMENTS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3002 |
| &nbsp;&nbsp;81. | NSG ILLINOIS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21658 |
| &nbsp;&nbsp;82. | PACY OLETSKY & BONNIE OLETSKY JT TEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5421 |
| &nbsp;&nbsp;83. | PEARL CAPITAL PARTNERS LP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;142 |
| &nbsp;&nbsp;84. | PIN PIN GREEN HOLDINGS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;909 |
| &nbsp;&nbsp;85. | PINE HAVEN LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3582 |
| &nbsp;&nbsp;86. | MARINA PLANINIC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14562 |
| &nbsp;&nbsp;87. | POINTS EAST LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23203 |
| &nbsp;&nbsp;88. | ANTHONY PORTNOY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;960 |
| &nbsp;&nbsp;89. | DAVID RABIN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5006 |
| &nbsp;&nbsp;90. | RAM PARTNERS LP | 5329 |
| &nbsp;&nbsp;91. | RBP HOLDINGS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1438 |
| &nbsp;&nbsp;92. | RELAY LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12589 |
| &nbsp;&nbsp;93. | RFK PARTNERS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2445 |
| &nbsp;&nbsp;94. | GEOFFREY RICH | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16376 |
| &nbsp;&nbsp;95. | PAULINE ROOP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;211 |
| &nbsp;&nbsp;96. | ALLAN B ROTHSCHILD | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2306 |
| &nbsp;&nbsp;97. | HOLLY RUBENSTEIN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;68 |
| &nbsp;&nbsp;98. | JEFF RUPP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;677 |
| &nbsp;&nbsp;99. | JEFFREY SALTZMAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11797 |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**No.** | **Name of Party** | **Number of Subordinate <br> Voting Shares to be Issued** |
| &nbsp;&nbsp;100. | JULIA GLAZER SCHER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3471 |
| &nbsp;&nbsp;101. | JAMES SCHLESINGER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22943 |
| &nbsp;&nbsp;102. | ALLEN N SCHWARTZ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7191 |
| &nbsp;&nbsp;103. | DRAZEN SENTIC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;529 |
| &nbsp;&nbsp;104. | SENVEST CAPITAL INC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32367 |
| &nbsp;&nbsp;105. | SENVEST MASTER FUND LP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;129470 |
| &nbsp;&nbsp;106. | PAUL SHELOWITZ & TRACY SHELOWITZ JT TEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1787 |
| &nbsp;&nbsp;107. | SHN FINANCIAL INVESTMENTS LTD | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3165 |
| &nbsp;&nbsp;108. | MATT SICLARI | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1587 |
| &nbsp;&nbsp;109. | ANNA GLAZER SIMON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3471 |
| &nbsp;&nbsp;110. | MARC SIMON | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29207 |
| &nbsp;&nbsp;111. | SOLIDUM CAPITAL ADVISORS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16444 |
| &nbsp;&nbsp;112. | COURTNEY STUPP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;113 |
| &nbsp;&nbsp;113. | PHILIP SU | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;212 |
| &nbsp;&nbsp;114. | MICHAEL D SULLIVAN & JEAN M SULLIVAN JT TEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9036 |
| &nbsp;&nbsp;115. | GARY SUMERS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;226 |
| &nbsp;&nbsp;116. | GARY M SUMERS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2645 |
| &nbsp;&nbsp;117. | DOUGLAS SYERS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;118. | TAILWINDS II LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1787 |
| &nbsp;&nbsp;119. | BARBARA E CHARAL TR BARBARA E CHARAL REVOCABLE TRUST U/A DTD 09/28/01 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4284 |
| &nbsp;&nbsp;120. | GARY SUMERS TR BRIAN SAKIN SUMERS 2015 LT TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2645 |
| &nbsp;&nbsp;121. | DIANE M LANDGREN 2001 TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50096 |
| &nbsp;&nbsp;122. | DOUGLAS C GESSNER TR DOUGLAS C GESSNER REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1813 |
| &nbsp;&nbsp;123. | FRED BLITT & SALLY BLITT TR FRED BLITT REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4452 |
| &nbsp;&nbsp;124. | GARY C BECKER TR GARY C BECKER REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3615 |
| &nbsp;&nbsp;125. | GEORGE C PAPPAS & CARRIE J PAPPAS TR GEORGE PAPPAS REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5025 |
| &nbsp;&nbsp;126. | JEFFREY B KATZ & JANICE E KATZ TR THE J4 KATZ FAMILY TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2645 |
| &nbsp;&nbsp;127. | JAMES LAWRENCE SUMERS 2015 LT TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2645 |
| &nbsp;&nbsp;128. | JAN E BERGER REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;129. | KAHN FAMILY INVESTMENT TRUST \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81867 |
| &nbsp;&nbsp;130. | LYNN MILLER SOCOL REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5832 |
| &nbsp;&nbsp;131. | MATTHEW S DARIN DECLARATION OF TRUST \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;222685 |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**No.** | **Name of Party** | **Number of Subordinate <br> Voting Shares to be Issued** |
| &nbsp;&nbsp;132. | MICHAEL H DUBOW REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4284 |
| &nbsp;&nbsp;133. | MICHAEL N ALPERT TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9093 |
| &nbsp;&nbsp;134. | PAUL A MEISTER REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;626 |
| &nbsp;&nbsp;135. | PEYTON HURST REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22614 |
| &nbsp;&nbsp;136. | YALE W SAGER REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014 |
| &nbsp;&nbsp;137. | MELISSA VERNER | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1029 |
| &nbsp;&nbsp;138. | JAMES M WEAVER JR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;581 |
| &nbsp;&nbsp;139. | WEISMAN HOLDINGS ARKANSAS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3239 |
| &nbsp;&nbsp;140. | WEISMAN HOLDINGS LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;79 |
| &nbsp;&nbsp;141. | WEISMAN HOLDINGS PENNSYLVANIA LLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8565 |
| &nbsp;&nbsp;142. | ALLISON WEISMAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20825 |
| &nbsp;&nbsp;143. | ROBERT WEISMAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;42036 |
| &nbsp;&nbsp;144. | STEVEN WEISMAN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18359 |
| &nbsp;&nbsp;145. | KEVIN J WELTMANN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;146. | CRAIG WIELANSKY & MAUREEN WIELANSKY JT TEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4322 |
| &nbsp;&nbsp;147. | WSM ASS LLC - INVESTMENT SERIES | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2116 |
| &nbsp;&nbsp;148. | JAMES YI | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1371 |
| &nbsp;&nbsp;149. | WEISMAN FAMILY TRUST 2019 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;334118 |
| &nbsp;&nbsp;150. | STEVEN R S WEISMAN REVOCABLE TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;299141 |
| &nbsp;&nbsp;151. | PATRICK LECKY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;791 |
| &nbsp;&nbsp;152. | PATRICK BURKE | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;791 |
| &nbsp;&nbsp;153. | MICHAEL D SHUH | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;791 |
| &nbsp;&nbsp;154. | MATTINA FAMILY TRUST 2015 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1319 |
| &nbsp;&nbsp;155. | NATIONAL BANK FINANCIAL INC TR BEACON SECURITIES LIMITED | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10021 |
| &nbsp;&nbsp;156. | NATIONAL BANK FINANCIAL INC TR GRAHAM PROHASKA A/C 5FKDJ4F (T67052) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1055 |
| &nbsp;&nbsp;157. | GMP SECURITIES LP TR A/C 300 2KM0 F | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;527 |
| &nbsp;&nbsp;158. | GMP SECURITIES LP TR A/C 410 YBM0 F | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1058 |
| &nbsp;&nbsp;159. | GEORGE PAPPAS & KAREN ALBEAN JT TEN | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;189 |
| &nbsp;&nbsp;160. | ASSURE MANAGEMENT SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10513 |
| &nbsp;&nbsp;161. | GUNDYCO TR STONECASTLE CANNABIS GROWTH FUND | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1055 |
| &nbsp;&nbsp;162. | GUNDYCO TR STONECASTLE FUND A/C 51500236-29 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3165 |
| &nbsp;&nbsp;163. | GUNDYCO TR KOICHA PARTNERS LP 51500770ADP | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2645 |
| &nbsp;&nbsp;164. | AARON KEAY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5274 |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**No.** | **Name of Party** | **Number of Subordinate <br> Voting Shares to be Issued** |
| &nbsp;&nbsp;165. | GLASS INVESTMENTS LP A/C 402 21682 25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1798 |
| &nbsp;&nbsp;166. | INTERWARD CAPITAL CORP A/C 402 203 08 21 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1375 |
| &nbsp;&nbsp;167. | MITCHELL KAHN \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9722 |
| &nbsp;&nbsp;168. | MITCHELL P KAHN REVOCABLE TRUST \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;300153 |
| &nbsp;&nbsp;169. | LAURENCE H LEVINE FAMILY DYNASTY TRUST | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11344 |
| &nbsp;&nbsp;170. | HIGH TIMES LLC (EDWARD & ANGELA RIST, JTWROS) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;889 |
| &nbsp;&nbsp;171. | HIGH TIMES LLC (LEROY & JOYEE MATERAZZI, JTWROS) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;444 |
| &nbsp;&nbsp;172. | HIGH TIMES LLC (JEFFREY & LEIGH MATERAZZI, JTWROS) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;444 |
| &nbsp;&nbsp;173. | HIGH TIMES LLC (NICOLE LLOYD) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;889 |
| &nbsp;&nbsp;174. | HIGH TIMES LLC (WILLIAM & JUDITH STROUP, JTWROS) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;889 |
| &nbsp;&nbsp;175. | GREEN KACH LLC (GARY GREENBERG) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1533 |
| &nbsp;&nbsp;176. | GREEN KACH LLC (DANIEL KACH) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1533 |
| &nbsp;&nbsp;177. | GREEN KACH LLC (JAMES KACH) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1131 |
| &nbsp;&nbsp;178. | CANNAMD HOLDINGS LLC (JENNY EWING & KEITH EWING) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;904 |
| &nbsp;&nbsp;179. | CANNAMD HOLDINGS LLC (ANDREW MEISTER) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;904 |
| &nbsp;&nbsp;180. | CWAZ LLC (ZACHARY ZISES) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12589 |
| &nbsp;&nbsp;181. | HELYN GOLDENBERG TRUST OFAC 235975 | 9093 |
| &nbsp;&nbsp;182. | ROY LANDGREN TRUST OFAC 236098 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25188 |
| &nbsp;&nbsp;183. | G-CUBED LLC OFAC 236268 | 1058 |
|  | **TOTAL:** | **3483581** |

---

**FORM 9 – NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF**

**LISTED SECURITIES**

September 2018